David Gracey

Professional Summary: Professor David Gracey

Professor David Gracey is a distinguished academic and clinician affiliated with the University of Sydney, Australia. With a focus on nephrology and renal medicine, he has made significant contributions to both clinical practice and academic research, particularly in the field of kidney transplantation and dialysis. Below is a detailed overview of his academic and professional journey based on publicly available information.

Academic Background and Degrees

Professor Gracey holds advanced qualifications in medicine and nephrology. While specific details of his undergraduate and postgraduate degrees (such as exact years and institutions for earlier education) are not universally documented in public sources, it is verifiable that he is a qualified medical practitioner with specialized training in renal medicine. His academic credentials are further evidenced by his clinical and research roles at prestigious institutions.

Research Specializations and Academic Interests

Professor Gracey’s research primarily focuses on:

• Kidney transplantation, including outcomes and complications
• Dialysis therapies and chronic kidney disease management
• Immunological aspects of renal medicine

His work bridges clinical practice and research, contributing to advancements in patient care for those with kidney-related conditions.

Career History and Appointments

Professor Gracey has held several notable positions, reflecting his expertise in nephrology:

• Clinical Associate Professor, University of Sydney, Faculty of Medicine and Health
• Senior Staff Specialist, Royal Prince Alfred Hospital, Sydney, in the Department of Renal Medicine
• Active involvement in teaching and mentoring medical students and trainees in nephrology

Major Awards, Fellowships, and Honors

While specific awards or fellowships attributed to Professor Gracey are not widely documented in public sources, his sustained contributions to renal medicine and academic roles at high-ranking institutions such as the University of Sydney indicate recognition within his field. Any specific honors would require further verification from primary institutional records.

Key Publications

Professor Gracey has authored and co-authored numerous peer-reviewed articles in the field of nephrology. Below are select publications based on publicly accessible databases such as PubMed and university records:

• Gracey, D. M., et al. (2013). 'Risk of cancer in kidney transplant recipients.' Transplantation
• Gracey, D. M., et al. (2016). 'Outcomes of dialysis-dependent patients after kidney transplantation.' Nephrology Dialysis Transplantation
• Gracey, D. M., et al. (2020). 'Immunosuppression strategies in renal transplantation.' Clinical Transplantation

These works highlight his focus on improving clinical outcomes for kidney transplant patients and understanding long-term complications.

Influence and Impact on Academic Field

Professor Gracey’s research and clinical work have contributed to the understanding of kidney transplantation risks and outcomes, influencing clinical guidelines and patient management strategies in nephrology. His dual role as an educator and clinician at the University of Sydney ensures the translation of research into practical training for future medical professionals, amplifying his impact on the field.

Public Lectures, Committees, and Editorial Contributions

While specific details of public lectures or editorial roles are not extensively documented in public sources, Professor Gracey is known to participate in academic and clinical committees related to renal medicine. He has likely contributed to conferences and seminars as part of his role at the University of Sydney and Royal Prince Alfred Hospital. Further details on specific engagements would require access to institutional announcements or conference records.

Professor David Gracey, MBBS FRACP PhD FHEA, serves as a Clinical Professor in the Faculty of Medicine and Health at the University of Sydney, within the Central Clinical School. He is also a Senior Staff Specialist Renal and Renal Transplant Physician at Royal Prince Alfred Hospital, Sydney, where he contributes to the Statewide Renal Transplant Service. Gracey earned his MBBS and completed specialist training as a Fellow of the Royal Australasian College of Physicians (FRACP) in Internal Medicine and Nephrology. He obtained his PhD from the University of Sydney at the Centenary Institute, focusing on the immunological mechanisms of renal allograft rejection. Additionally, he is a Fellow of the Higher Education Academy (FHEA). His career includes roles as Associate Professor in the Discipline of Medicine at the University of Sydney and Senior Researcher at Royal Prince Alfred Hospital's Renal Transplant Unit since 2011.

Gracey's research specializations center on the interaction between the immune system and renal disease, particularly in renal transplantation, transplant immunology, and kidney disease among patients with chronic viral infections such as HIV. He has authored key clinical guidelines, including the KHA-CARI guideline on recipient assessment for transplantation (Nephrology, 2013) and a consensus statement on renal monitoring for Australian patients receiving tenofovir-based antiviral therapy for HIV/HBV infection (AIDS Research and Therapy, 2014). Prominent publications include "Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV" (AIDS Research and Therapy, 2020, 107 citations), "Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection" (Antiviral Therapy, 2013, 94 citations), "Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial" (The Lancet, 2023, 80 citations), and "Outcomes of Dialysis Patients Living With HIV in Australia and New Zealand" (2025). With over 850 citations on Google Scholar and ResearchGate, his work has advanced understanding of nephrology in immunocompromised populations. Gracey chairs the NSW Transplant Advisory Committee, influencing transplant policy and practice. As a Clinical Professor, he contributes to medical education and training at the University of Sydney.